BPC + TB

BPC-157 + TB-500 is a research peptide blend combining two synthetic peptides commonly investigated in preclinical and laboratory research. BPC-157 is studied in connection with cellular signaling, angiogenesis-related mechanisms, and tissue-remodeling pathways, while TB-500 is studied in connection with thymosin beta-4-related pathways, actin-associated processes, and cellular migration.

The combination may be utilized in controlled laboratory research examining interactions between these pathways and related cellular and biological mechanisms.

Research Classification: Synthetic research peptide blend Form: Lyophilized peptide blend

Intended Use: Laboratory research

Research Use Only. Not for human or veterinary use. This product is intended solely for qualified laboratory research and analytical applications. It is not intended to diagnose, treat, cure, or prevent any disease.